Topotecan Completed Phase 1 Trials for Esophageal Cancers / Lung Cancers / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00287963Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00322751Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
NCT00002537Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
NCT00002625Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma